Literature DB >> 6522924

Tissue penetration and half-life of cefonicid.

C H Nightingale, R Quintiliani, M N Dudley, P Gough, M Hickingbotham, N S Jordan, D Rose, M Toscani.   

Abstract

The pharmacokinetics of cefonicid in the serum and tissues of patients undergoing open heart surgery, vaginal hysterectomy, and hip replacement was studied and compared with that of cefazolin and cefoxitin. Cefonicid achieved serum and tissue concentrations that were higher and more prolonged than those of cefazolin and cefoxitin. For cefonicid parallelism was observed between the serum and tissue concentration-time curves. Correlations of these properties to clinical efficacy were not attempted.

Entities:  

Mesh:

Substances:

Year:  1984        PMID: 6522924     DOI: 10.1093/clinids/6.supplement_4.s821

Source DB:  PubMed          Journal:  Rev Infect Dis        ISSN: 0162-0886


  6 in total

1.  Effect of saturable serum protein binding on the pharmacokinetics of unbound cefonicid in humans.

Authors:  M N Dudley; W C Shyu; C H Nightingale; R Quintiliani
Journal:  Antimicrob Agents Chemother       Date:  1986-10       Impact factor: 5.191

2.  Antistaphylococcal activity of ceforanide and cefonicid in the presence of human serum.

Authors:  A L Barry; R N Jones; R R Packer
Journal:  Antimicrob Agents Chemother       Date:  1986-01       Impact factor: 5.191

Review 3.  Considerations in dosage selection for third generation cephalosporins.

Authors:  J H Yuk-Choi; C H Nightingale; T W Williams
Journal:  Clin Pharmacokinet       Date:  1992-02       Impact factor: 6.447

Review 4.  Cefonicid. A review of its antibacterial activity, pharmacological properties and therapeutic use.

Authors:  E Saltiel; R N Brogden
Journal:  Drugs       Date:  1986-09       Impact factor: 9.546

5.  Cefonicid versus clindamycin prophylaxis for head and neck surgery in a randomized, double-blind trial, with pharmacokinetic implications.

Authors:  D Swanson; R A Maxwell; J T Johnson; R L Wagner; V L Yu
Journal:  Antimicrob Agents Chemother       Date:  1991-07       Impact factor: 5.191

6.  Aztreonam concentrations in human tissues obtained during thoracic and gynecologic surgery.

Authors:  T R Beam; R P Galask; L T Friedhoff; T B Platt; M A Leitz
Journal:  Antimicrob Agents Chemother       Date:  1986-09       Impact factor: 5.191

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.